Second Phase-III-Induction Study (U-ACCOMPLISH) of Upadacitinib confirms improved clinical, endoscopic and histological Results in Patients with Ulcerative colitis

被引：0
|
作者：
不详
机构：
来源：
VISCERAL MEDICINE | 2021年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [41] CORRELATION OF HISTOLOGICAL ASSESSMENT OF MUCOSAL HEALING WITH LONG-TERM CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS TREATED WITH UPADACITINIB: RESULTS FROM PHASE 3 U-ACHIEVE MAINTENANCE TRIAL
    Parke, Gareth
    Ungaro, Ryan C.
    Danese, Silvio
    Abreu, Maria T.
    Arenson, Ethan
    Zhou, Wen
    Ilo, Dapo
    Laroux, Stephen
    Deng, Huiwen
    Gonzalez, Yuri Sanchez
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2022, 162 (07) : S970 - S970
  • [42] Upadacitinib Is Effective at Inducing Clinical Remission and Response in Ulcerative Colitis Patients Regardless of Baseline Corticosteroid Use: Results From Two Phase 3 Studies
    Rubin, David T.
    Raine, Tim
    Finney-Hayward, Tricia
    Loftus, Edward V.
    Targownik, Laura
    Ilo, Dapo
    Phillips, Charles
    Yao, Xuan
    Vermeire, Severine
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S397 - S397
  • [43] Efficacy of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis by Biologic Inadequate Responder Status: Results From Two Randomized Phase 3 Studies
    Vermeire, Severine
    Tanida, Satoshi
    Hu, Renwei
    Panaccione, Remo
    Hebuterne, Xavier
    Rubin, David T.
    Ilo, Dapo
    Zhou, Wen
    Weinreich, Michael
    Zhou, Qing
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S398 - S399
  • [44] Ustekinumab Improved Work Productivity in Patients With Moderate to Severe Ulcerative Colitis: Results From the Phase 3 UNIFI Induction and Maintenance Studies
    Han, Chenglong
    Naessens, Dominik
    Zhang, Hongyan
    Johanns, Jewel
    Marano, Colleen
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S438 - S438
  • [45] Upadacitinib modulates inflammatory pathways in gut tissue in patients with Ulcerative Colitis: Transcriptomic profiling from the Phase 2b study, U-ACHIEVE
    Verstockt, B.
    Polakow, S. Blink
    Mahi, N.
    Lee, J.
    Wang, J.
    Guay, H.
    Salas, A.
    Panes, J.
    Ungaro, R. C.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I033 - I034
  • [46] Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial
    Yarur, Andres J.
    Chiorean, Michael, V
    Panes, Julian
    Jairath, Vipul
    Zhang, Jinkun
    Rabbat, Christopher J.
    Sandborn, William J.
    Vermeire, Severine
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 885 - 894
  • [47] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 QUASAR INDUCTION STUDY
    Allegretti, Jessica R.
    Peyrin-Biroulet, Laurent
    Feagan, Brian G.
    Bressler, Brian
    Lichtenstein, Gary R.
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Shipitofsky, Nicole
    Jiang, Lingjing
    Zhang, Hongyan
    Hisamatsu, Tadakazu
    Panes, Julian
    Dignass, Axel
    Sands, Bruce E.
    Rubin, David T.
    GASTROENTEROLOGY, 2023, 164 (06) : S1572 - S1572
  • [48] The effects of maintenance therapy with upadacitinib on abdominal pain, bowel urgency, and fatigue in patients with moderately to severely active Ulcerative Colitis: Phase 3 U-ACHIEVE maintenance results
    Danese, S.
    Tran, J.
    D'Haens, G.
    Rubin, D. T.
    Aoyama, N.
    Zhou, W.
    James, B.
    Yao, X.
    Gonzalez, Y. Sanchez
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I008 - I009
  • [49] THE EFFECTS OF MAINTENANCE THERAPY WITH UPADACITINIB ON ABDOMINAL PAIN, BOWEL URGENCY, AND FATIGUE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 3 U--ACHIEVE MAINTENANCE RESULTS
    Danese, Silvio
    Tran, Jacinda
    D'Haens, Geert R.
    Rubin, David T.
    Aoyama, Nobuo
    Zhou, Wen
    James, Barbara
    Yao, Xuan
    Gonzalez, Yuri Sanchez
    Panaccione, Remo
    GASTROENTEROLOGY, 2022, 162 (07) : S972 - S972
  • [50] General health status in patients with moderate to severe ulcerative colitis receiving ustekinumab: Results from the Phase III UNIFI induction and maintenance studies
    Danese, S.
    Sands, B.
    Leong, R.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Han, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 135 - 137
12345